Additional studies are needed to determine if reduced cerebral perfusion following chemotherapy impairs clearance of Aβ and if activity of P-glycoprotein 1 in AD is sufficiently reduced to cause neurologically consequential higher concentrations of chemotherapeutic agents in the brain. The gene discussed is ABCB1; the disease is Alzheimer disease.